Jaktinib Hydrochloride Tablets In The Treatment of Active Ankylosing Spondylitis
Clinical trial NCT04507659 · COMPLETED
Trial details
- NCT number
- NCT04507659
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2022-08-02
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.